The global aneurysm clips market was valued at USD 907.9 million in 2021 and it is predicted to surpass around USD 1.57 billion by 2030 with a CAGR of 6.24% from 2022 to 2030.
Market Synopsis
Aneurysm clipping is a surgical procedure used to treat brain aneurysms. It entails attaching a metal clip to the aneurysm's neck, which connects to the blood vessel from which it originated. Restricting blood from entering the aneurysm, helps to prevent the aneurysm from rupturing. Once the aneurysm clip is in position, it remains there permanently inside the skull, allowing the aneurysm to gradually contract while keeping the blood vessel nearby open. Aortic aneurysms are thought to be the cause of over 9,904 deaths in the U.S, according to CDC in 2019. Aneurysm clips come in a variety of sizes and forms since aneurysms typically vary in size and shape.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 907.9 million |
| Revenue Forecast by 2030 | USD 1.57 billion |
| Growth rate from 2022 to 2030 | CAGR of 6.24% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Material, Aneurysm Type, End-Users, Region |
| Companies Covered |
B. Braun Melsungen AG (Aesculap USA), Datenschutz/Rebstock Instruments GmbH, Peter LAZIC GmbH, Squadhouse Media - Werbeagentur Tuttlingen, Ortho-Medical GmbH, Codman & Shurtleff, Stryker, Medtronic, Boston Scientific, St. Jude Medical, Integra LifeSciences, Gebrüder Martin GmbH & Co. KG klsmartin, adeor medical AG , others |
Market Influencer
An increase in the incidence of brain aneurysms in several countries is anticipated to impact the market growth over the forecast period. A brain aneurysm is characterized by a balloon-like swelling in the blood vessel inside the brain, which generally appears in the lower regions of the brain. It is also termed as intracranial aneurysm or cerebral aneurysm. This aneurysm can rupture and cause bleeding in the adjoining subarachnoid space, thereby leading to a stroke or brain hemorrhage. For instance,around 200 aneurysm cases are treated at Johns Hopkins, one of the few hospitals in the nation, each year.
Furthermore, companies are focused on adopting extensive growth strategies such as increasing product diversification & differentiation of product portfolio, entering into strategic alliances, and broadening marketing and distribution channels in an attempt to increase the outreach of their products and gain a competitive edge which is expected to provide this market with lucrative growth opportunities. For instance,
These mergers and acquisitions are expected to boost the aneurysm clips market growth over the forecast period. However, the presence of alternatives such as endovascular treatment along with the high cost of treatment are expected to obstruct market growth.
Key Players
Market Segmentation
By Material Outlook
By Aneurysm Type Outlook
By End-Users Outlook
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Aneurysm Clips Market
5.1. COVID-19 Landscape: Aneurysm Clips Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Aneurysm Clips Market, By Material
8.1. Aneurysm Clips Market, by Material, 2022-2030
8.1.1 Titanium Aneurysm Clip
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Cobalt-Chromium Aneurysm Clip
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Aneurysm Clips Market, By Aneurysm Type
9.1. Aneurysm Clips Market, by Aneurysm Type, 2022-2030
9.1.1. Abdominal
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Cerebral
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Thoracic
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Peripheral
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Aneurysm Clips Market, By End-Users
10.1. Aneurysm Clips Market, by End-Users, 2022-2030
10.1.1. Hospitals and Cardiac Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Ambulatory Surgical Centers
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Aneurysm Clips Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Material (2017-2030)
11.1.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Material (2017-2030)
11.2.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Material (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Material (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Material (2017-2030)
11.3.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Material (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Material (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Material (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Material (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Material (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Material (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Aneurysm Type (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
Chapter 12. Company Profiles
12.1. B. Braun Melsungen AG (Aesculap USA)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Datenschutz/Rebstock Instruments GmbH
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Peter LAZIC GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Squadhouse Media - Werbeagentur Tuttlingen
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ortho-Medical GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Codman & Shurtleff
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Stryker
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medtronic
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Boston Scientific
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. St. Jude Medical
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers